Affiliation:
1. NU Hospitals
2. Department of Urology, Hospital La Zarzuela, Madrid, Spain
3. Hm Sanchinarro
Abstract
Abstract
Penile prosthesis (PP) in Peyronie’s disease (PD) is considered only when pharmacotherapy has failed in management of erectile dysfunction (ED). Patients with PD who underwent PP (malleable or inflatable) with or without additional maneuvers like manual modeling and grafting from 2012 to 2022 were included in the study. Patient and partner satisfaction were assessed using a 5-point Likert scale. ED was assessed using a validated questionnaire. A total of 168/636 patients underwent PP as first-line surgical management for PD and were included in the study. The mean age was 56.3 years +/- 12.4 and a median BMI of 27.2. Mean follow-up was 56 months (95% CI: 11-21). All 168 patients had undergone additional maneuvers such as manual modeling in 85.7% and grafting in 14.3%. Majority of the patients underwent a 3-piece inflatable PP (86.9%). Thirty-three (19.7%) PD patients without ED had undergone PP. The satisfaction of PD patients with ED and without ED was not statistically different (88.9% vs 87.9%). If surgery is offered in PD, PP may be considered as a first-line surgical treatment regardless of the ED in view of the acceptable complications and high satisfaction rates.
Publisher
Research Square Platform LLC
Reference31 articles.
1. Peyronie's disease;Taylor FL;Urol Clin North Am,2007
2. Deformity stabilization and improvement in men with untreated Peyronie's disease;Berookhim BM;BJU Int,2014
3. An analysis of the natural history of Peyronie’s disease;Mulhall JP;J Urol,2006
4. The etiology of Peyronie’s disease: pathogenesis and genetic contributions;Sharma KL;Sex Med Rev,2020
5. Medical Management of Peyronie's Disease: Review of the Clinical Evidence;Teloken P;Med Sci (Basel),2019